Organon & Co | OGN - 売上原価

株価
8.83
毎日の変更
1.92 27.79%
毎月
37.97%
毎年
-20.91%
Q2 予測
8.59




売上原価 変化する 日付
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Celltrion KRW 402.86B 14.24B 2025-09
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Deva Holding AS TRY 991.13M 182.81M 2023-09
Divis Laboratories Ltd INR 10.63B 1.23B 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
Glaxosmithkline GBP 3.47B 461.37M 2025-12
Kangmei Pharma CNY 1.11B 84.66M 2025-09
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Medical Developments International AUD 7.09M 4.91M 2025-12
Merck USD 3.32B 531M 2025-12
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
Novartis USD 3.54B 7M 2025-12
Organigram Holdings CAD 56.93M 20.53M 2025-12
Organon & Co USD 745M 25M 2025-09
Pharma Mar EUR 3.77M 1.47M 2025-12
Qiagen NV USD 217.43M 29.65M 2025-12
Sartorius EUR 450M 18.1M 2025-09
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Tilray USD 164.37M 8.41M 2025-09
Zealand Pharma A/S 410K 5K 2025-06